TAG Biosciences is creative and enthusiastic partnership whose team members have accumulated a vast experience in the main fields of clinical diagnostics industry, such as instrumentation design, reagent formulation and applications, and global strategies for commercial market positioning and distribution. Our commercial objective is to design and market at a global level, innovative instrumentation and reagents for applications, with the mind in POCT market segment.
Therefore, our commercial strategy is to develop a family of POCT instrumentation with a comprehensive menu of tests, by adapting latest technologies available, with special emphasis in CRISPR - still in its introductory life cycle stage, which has shown to be the future of clinical diagnostics IVD testing.
Describes our commitment to design a product mix with latest technology available, by adding a concept of simplicity with user – friendly operational procedures.
TAG Biosciences is committed to providing reliable innovations for the present and the future of clinical diagnostics.
© 2023 TAG Biosciences, Inc. All rights reserved.
